Praxbind and Pradaxa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Praxbind (idarucizumab) and Pradaxa (dabigatran etexilate mesylate). Common drug interactions include abdominal discomfort among females and gastrointestinal haemorrhage among males.
The phase IV clinical study analyzes what interactions people have when they take Praxbind and Pradaxa. It is created by eHealthMe based on reports of 131 people who take the same drugs from the FDA, and is updated regularly.
What is Praxbind?
Praxbind has active ingredients of idarucizumab. eHealthMe is studying from 1,391 Praxbind users. Check the latest studies of Praxbind.
What is Pradaxa?
Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
131 people who take Praxbind and Pradaxa together, and have interactions are studied.
What are the common drug interactions of Praxbind and Pradaxa, by gender? *
What are the common drug interactions of Praxbind and Pradaxa, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Praxbind and Pradaxa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Praxbind and Pradaxa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Praxbind:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pradaxa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Praxbind and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pradaxa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on idarucizumab and dabigatran etexilate mesylate (the active ingredients of Praxbind and Pradaxa, respectively), and Praxbind and Pradaxa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Sprycel and Furosemide - a second ago
- Drug interactions of Movantik and Lyrica - a second ago
- Wellbutrin and Gallbladder Attack for Women aged 20-29 - 11 seconds ago
- Wellbutrin and Biliary Disease for Women aged 20-29 - 11 seconds ago
- Wellbutrin and Biliary Colic for Women aged 20-29 - 11 seconds ago
- Wellbutrin and Gallbladder Disease for Women aged 20-29 - 12 seconds ago
- Hair Loss and drugs of ingredients of tranexamic acid - 12 seconds ago
- Eosinophilic Pneumonia and drugs of ingredients of quetiapine fumarate - 13 seconds ago
- Maxzide vs. Zoloft, side effect and effectiveness comparison - 15 seconds ago
- Lexapro and Meloxicam drug interactions for women aged 60+ - 16 seconds ago